Thomas M Tu MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Join to View Full Profile
3900 Kresge WaySuite 60Louisville, KY 40207
Phone+1 502-893-7710
Fax+1 502-893-1391
Are you Dr. Tu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Tu, MD is a cardiologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Interventional Cardiology, 2002 - 2003- Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1999 - 2002
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1999
Harvard Medical SchoolClass of 1996
Certifications & Licensure
KY State Medical License 2003 - 2026
Publications & Presentations
PubMed
- 31 citationsPercutaneous thrombectomy in patients with massive and very high-risk submassive acute pulmonary embolism.Catalin Toma, Sameer Khandhar, Adrian Zalewski, Stephen D'Auria, Thomas M. Tu
Catheterization and Cardiovascular Interventions. 2020-08-31 - 10 citationsPercutaneous Thrombectomy in Emergency Department Patients with Pulmonary Embolism: The FLARE ED Sub-studyWissam Jaber, Christopher Kabrhel, Kenneth Rosenfield, Thomas Tu, Kenneth Ouriel
The Journal of Emergency Medicine. 2020-02-01 - 299 citationsA Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE StudyThomas Tu, Catalin Toma, Victor F. Tapson, Christopher Adams, Wissam Jaber
JACC. Cardiovascular Interventions. 2019-05-13
Press Mentions
Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism PatientsMay 22nd, 2023- FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever SystemMarch 6th, 2023
- Inari Medical Begins Subject Enrolment in ClotTriever System TrialJanuary 13th, 2023
- Join now to see all
